Hypopituitarism – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:16:38 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Hypopituitarism – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effects of Exenatide in Patients with Hypopituitarism and Oxytocin Deficiency https://clinicaltrials.eu/trial/study-on-the-effects-of-exenatide-in-patients-with-hypopituitarism-and-oxytocin-deficiency/ Wed, 29 Apr 2026 15:05:29 +0000 https://clinicaltrials.eu/trial/study-on-the-effects-of-exenatide-in-patients-with-hypopituitarism-and-oxytocin-deficiency/ This clinical trial is focused on studying hypopituitarism, a condition where the pituitary gland does not produce enough hormones. The study will explore the effects of a medication called Byetta, which contains the active substance exenatide. This medication is a type of glucagon-like peptide analogue, which is usually used to help control blood sugar levels in people with diabetes. In this study, it will be used to understand its impact on hormone secretion in patients with hypopituitarism.

The purpose of the study is to improve knowledge about how the body naturally produces a hormone called oxytocin in people with hypopituitarism. Participants will receive either the study medication or a placebo, and the study will follow a randomized, crossover design. This means that participants will receive both the medication and the placebo at different times during the study. The study will look at how the medication affects the pattern of oxytocin hormone secretion.

Throughout the study, researchers will also assess various aspects of participants’ well-being, such as mood, quality of life, and eating behavior, to see how these might be related to changes in oxytocin levels. The study is expected to continue until the end of 2024, providing valuable insights into the relationship between hypopituitarism and oxytocin production.

]]>